Sail Biomedicines
Sail Biomedicines, a Flagship Pioneering Company based in Cambridge, MA, is at the forefront of developing programmable medicines through the innovative use of evolution and AI. Their groundbreaking bioplatform combines translatable circular RNA technology and proprietary programmable nanoparticles to create fully programmable medicines with unprecedented performance and broad applicability.
By leveraging their rapid prototyping abilities and proprietary AI algorithms, Sail is advancing integratively designed RNA medicines for the potential treatment of various diseases, including oncology, metabolic disease, infectious diseases, rare diseases, and immunology. With their unique combination of cutting-edge technologies, Sail Biomedicines aims to generate life-changing impact for people worldwide.
Generated from the website
Also at this address
You might also like
Partial Data by Infogroup (c) 2025. All rights reserved.